| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Davuluri Rama Mohan Rao CEO | MSE Exchange | INE794A01010 ISIN |
| IN Country | 1,794 Employees | 24 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Neuland Laboratories Limited is an esteemed manufacturer and global distributor of active pharmaceutical ingredients (APIs), headquartered in Hyderabad, India. Since its inception in 1984, Neuland Laboratories has been at the forefront of producing high-quality APIs for various therapeutic areas, catering to clients in India, the United States, Europe, and other international markets. In addition to its core API production, Neuland Laboratories prides itself on offering specialized custom manufacturing solutions and peptide synthesis services to meet the evolving needs of the pharmaceutical industry.
Neuland Laboratories' portfolio includes APIs used in a wide range of therapeutic fields such as antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson diseases. By focusing on these extensive therapeutic areas, Neuland ensures its products meet the diverse needs of healthcare providers and patients globally.
Leveraging its extensive expertise in API development and manufacturing, Neuland Laboratories provides tailor-made manufacturing solutions to pharmaceutical companies. These custom services range from the development of unique chemical processes to the scale-up and production of APIs. This flexibility and customization allow Neuland to partner effectively with clients across different stages of drug development and manufacturing.
Understanding the growing importance of peptides in therapeutic applications, Neuland Laboratories offers specialized peptide synthesis services. This service encompasses both the development and the manufacture of peptides using advanced synthesis technologies. Neuland’s capabilities in peptide synthesis enable it to support the pharmaceutical industry's demand for both standard and complex peptides.